The potential clinical utility of circulating tumor cells (CTCs) in the diagnosis and
management of cancer has drawn a lot of attention in the past 10 years. CTCs disseminate …

Cancer is considered as the leading cause of death and the major barrier of longevity
globally. The high mortality of cancer is due to the malignant spread. However, if the disease …

Circulating tumor cells (CTCs) have shown promising potential as liquid biopsies that
facilitate early detection, prognosis, therapeutic target selection and monitoring treatment …

The mutational and phenotypic landscape of tumors is dynamic, requiring constant
monitoring of cancer patients to provide the most up-to-date and effective care. Circulating …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

One of the most promising developments in translational cancer medicine has been the
emergence of circulating tumor cells (CTC) as a minimally invasive multifunctional …

Circulating tumor cells (CTCs) have emerged as pivotal biomarkers with significant
predictive and prognostic implications in solid tumors. Their presence in peripheral blood …

Simple Summary Circulating tumour cells (CTCs) are cancer cells shed into the bloodstream
from tumours and their analysis can provide important insights into cancer detection and …

Circulating tumor cells (CTCs) have long been assumed to be the substrate of cancer
metastasis. However, only in recent years have we begun to leverage the potential of CTCs …

Circulating tumor cells (CTCs) are rare cancer cells released from tumors into the
bloodstream that are thought to have a key role in cancer metastasis. The presence of CTCs …